Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Matthew Genet"'
Autor:
Nicholas Xiao, Matthew Genet, Rocio Marquez Karry, Elias Hohlastos, Jennifer Karp, Kush Desai
Publikováno v:
CVIR Endovascular, Vol 7, Iss 1, Pp 1-6 (2024)
Abstract Purpose We hypothesize that single-procedure venous-specific rheolytic thrombectomy for treatment of acute iliofemoral deep venous thrombosis (DVT) will result in improved clinical symptoms as measured by the venous clinical severity score (
Externí odkaz:
https://doaj.org/article/4b38c1683d4548a68d058f8db6055c1f
Autor:
Derek A. Wainwright, Roger Stupp, Craig Horbinski, Charles D. James, Francis J. Giles, Jeffrey A. Sosman, David C. Binder, Priscilla K. Brastianos, Balázs Győrffy, Galina Gritsina, Matthew Genet, Meijing Wu, Kristen L. Lauing, Erik Ladomersky, Lijie Zhai
Description of Supplementary Tables 1-5 that support the expression and clinical relevance of IDO1 in grades II and III glioma, as well as GBM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2332c3e7bebf670aea764df91787fc24
https://doi.org/10.1158/1078-0432.22469210.v1
https://doi.org/10.1158/1078-0432.22469210.v1
Autor:
Derek A. Wainwright, Roger Stupp, Craig Horbinski, Charles D. James, Francis J. Giles, Jeffrey A. Sosman, David C. Binder, Priscilla K. Brastianos, Balázs Győrffy, Galina Gritsina, Matthew Genet, Meijing Wu, Kristen L. Lauing, Erik Ladomersky, Lijie Zhai
Description of Materials and Methods used to generate the novel IDO1-overexpressing U87 cell line, Western blotting, RT-PCR, cancer genome atlas analysis, as well as high performance liquid chromatography.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0519b7327be62db20559b6b56c112e0f
https://doi.org/10.1158/1078-0432.22469213
https://doi.org/10.1158/1078-0432.22469213
Autor:
Derek A. Wainwright, Roger Stupp, Craig Horbinski, Charles D. James, Francis J. Giles, Jeffrey A. Sosman, David C. Binder, Priscilla K. Brastianos, Balázs Győrffy, Galina Gritsina, Matthew Genet, Meijing Wu, Kristen L. Lauing, Erik Ladomersky, Lijie Zhai
Description of Supplementary Figures 1-9 that support the expression and clinical relevance of IDO1 in human GBM.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e865efa6e1324fa537eb8f53dc7a4e
https://doi.org/10.1158/1078-0432.22469216
https://doi.org/10.1158/1078-0432.22469216
Autor:
Jennifer D. Wu, Gary E. Schiltz, Lakshmi Reddy Bollu, Simon J. Clark, Peiwen Chen, Brian Wray, Kristen L. Lauing, Riyue Bao, Craig Horbinski, Erik Ladomersky, Rajesh Acharya, April Bell, Miri Kim, Richard D. Unwin, Matthew J. Schipma, Rimas V. Lukas, Matthew Genet, Derek A. Wainwright, Lijie Zhai, John R. Griffiths, Xinlei Mi, Brenda Nguyen
Publikováno v:
Clin Cancer Res
Purpose: Glioblastoma (GBM) is an incurable primary brain tumor that has not benefited from immunotherapy to date. More than 90% of GBM expresses the tryptophan (Trp) metabolic enzyme, indoleamine 2,3-dioxygenase 1 (IDO). This observation supported t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb3cd18f037b33ffc3e757f421dbba6
https://doi.org/10.1158/1078-0432.ccr-21-1392
https://doi.org/10.1158/1078-0432.ccr-21-1392
Publikováno v:
Journal of Vascular and Interventional Radiology. 30:1689-1691
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e11e4dbd7b9d535fdacaf4ec1bf10b1
https://doi.org/10.1016/j.jvir.2018.10.010
https://doi.org/10.1016/j.jvir.2018.10.010
Autor:
Simon J. Clark, Riyue Bao, April Bell, Kristen L. Lauing, Rajesh Acharya, Rimas V. Lukas, Matthew Genet, Gary E. Schiltz, John R. Griffiths, Brian Wray, Jennifer D. Wu, Matthew J. Schipma, Lijie Zhai, Derek A. Wainwright, Erik Ladomersky, Xinlei Mi, Craig Horbinski, Richard D. Unwin, Lakshmi Reddy Bollu, Masha Kocherginski, Miri Kim, Brenda Nuygen
Publikováno v:
Neuro-Oncology. 23:vi94-vi94
OBJECTIVE Indoleamine 2,3-dioxygenase 1 (IDO; IDO1) is an immune checkpoint that’s characterized as a potent immunosuppressive mediator through its ability to metabolize tryptophan and wild-type IDH patient-resected glioblastoma (GBM) expresses IDO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12fc298d2f0cf009f11f5bae9c08c022
https://doi.org/10.1093/neuonc/noab196.371
https://doi.org/10.1093/neuonc/noab196.371
Autor:
Erik Ladomersky, Derek A. Wainwright, Lijie Zhai, C. David James, Meijing Wu, Galina Gritsina, Matthew Genet, Kristen L. Lauing
Publikováno v:
Neuroscience Letters. 630:203-208
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, with an average age of 64 years at the time of diagnosis. To study GBM, a number of mouse brain tumor models have been utilized. In these animal models, subjects tend to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec28fc1e7d75a31b86f4bfa784f1b32f
https://doi.org/10.1016/j.neulet.2016.08.002
https://doi.org/10.1016/j.neulet.2016.08.002
Autor:
Lijie Zhai, David D. Odell, Srinadh Komanduri, Alfred Rademaker, Matthew Genet, Mary F. Mulcahy, Ari Rosenberg, Marie Pier Tetreault, Victoria M. Villaflor, Carlos Galvez, Kristen L. Lauing, Derek A. Wainwright, John P. Hayes, Kwang-Youn Kim, Craig Horbinski
Publikováno v:
Oncotarget
// Ari J. Rosenberg 4, 9 , Derek A. Wainwright 1, 2 , Alfred Rademaker 1, 3 , Carlos Galvez 4 , Matthew Genet 4 , Lijie Zhai 2 , Kristen L. Lauing 2 , Mary F. Mulcahy 1, 4, 9, 10 , John P. Hayes 1, 5 , David D. Odell 1, 6 , Craig Horbinski 1, 7 , Sri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8607fea36ec3e3416fac791bef798b7
https://pubmed.ncbi.nlm.nih.gov/29805749
https://pubmed.ncbi.nlm.nih.gov/29805749
Autor:
C. David James, Lijie Zhai, Derek A. Wainwright, Alicia Lenzen, Orin Bloch, Matthew Genet, Kristen L. Lauing, Erik Ladomersky, Galina Gritsina
Publikováno v:
Immunotherapy (Los Angeles, Calif.), vol 2, iss 3
The discovery that immunotherapy is a clinically-relevant approach for the treatment of malignant tumors is revolutionizing patient care. In adults diagnosed with glioblastoma (GBM), an aggressive and incurable primary brain tumor, autologous HSPPC-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ef917a87ec8f08c4af54a4a9236445
https://escholarship.org/uc/item/21196508
https://escholarship.org/uc/item/21196508